# AbbVie to Buy Immunology Drugmaker Apogee for $10.9 Billion

> **Open Intelligence Dossier** · First detected: 2026-06-22 19:07 UTC · Category: Business

## Executive Summary
4 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.

## Intelligence Brief
"AbbVie to Buy Immunology Drugmaker Apogee for $10.9 Billion" is generating significant coverage in the Business category, with 4 articles from 4 distinct sources tracked by PULSE so far.


Outlets currently covering the story include Whalesbook, GuruFocus, RAPS.org and The Business Journals. PULSE measures a story's velocity from how quickly new articles appear and how many independent newsrooms join the coverage.


This brief was generated by PULSE's extractive engine from coverage metadata only. The latest headlines from every source are listed below; the velocity chart shows how the story is developing in real time.

## Multi-Source Evidence Table
| Source Outlet | Headline | Verification URL |
|---|---|---|
| NBC Boston | AbbVie paying $10.9B to buy Waltham biotech | [Source Link](https://news.google.com/rss/articles/CBMirwFBVV95cUxNRlpRVXBCX0Rqd2VTWS05YmRsYnlHVDBuNE9hRk1MNTlsZl9QSkNBTUVvSFRWNm00akoyTG1zRXhpUkhjWER2UjMzdUZMYkFSV0JHMmxSenlGTFNKc0MzMXAzdlFUVXJxOGFnaVdmdHdpTVpyZXNCMkxtZ19Dc1FmNUNQZXRVaTRmUWFTMUt4ZnVmNlNtV3hRNERNckdSSlRCSWU5eXNLVmloTExfQ3p30gG3AUFVX3lxTE0wczQ1bmhtSUdsREg5RzZDWnBLcWZYSkFPaGtVb1NkeUVhN0p1SEtrYnlhaHV5M3BLZFkyTzFjaXFuV2J5VW5uNHpTOUgtQVhkdExWZkdnblRYNlNvT3VndVNfWllFbldEU21qUUtENTRkWi14T2VvX2tLMkZpX1dFMTZOLWRwNzhCajZPY0I2blVWMEM1My1Kd2lXQ014NVZicEs) |
| Yahoo Finance | 3 Biotech Takeover Targets Wall Street Is Watching After the Apogee Deal | [Source Link](https://news.google.com/rss/articles/CBMilwFBVV95cUxOS2lBS2lqa2NaTDFudkdZY1ZzWjJ4dFA0OUxxUS16NjNrQ09OTzBxa0xuRGUwM2RKbm83bmxZdnhPMVhOSnZxRFFlMkptTENKVmlaT3NsUjdfQUNXc0VPS0tjWVRiUmZHd25Rckl0TDNLdmNHUjB0aEJka293cjVqQXV5cVJwRGNnNXFrYnRzYTktUC1RaVlV?oc=5) |
| Barron's | Why AbbVie Is Spending $11 Billion to Buy Apogee Therapeutics—and Why the Stock Is Rising | [Source Link](https://news.google.com/rss/articles/CBMiggFBVV95cUxPc0tVT0o5Q0piVzBQakZ0QkZXOXJPbjBRNGg3SUt4NHZUeXh6QU1vQzRpdWRTMTllM0h4NDFWTS1rMGNrU1NhSV9RVFNxdnVUZHQyV2FSMzU4bVlXS0RxRUowd3NSQjdaTGJnaURZR0VOdWwxMWRjRWRsYm12R0FOZmdn?oc=5) |
| Investor's Business Daily | AbbVie Goes On The Offensive With $10.9 Billion Takeover | [Source Link](https://news.google.com/rss/articles/CBMimgFBVV95cUxNM01TYno1alhZU0J0bTF6NEdGdTlpY0ltTVdMekluZ3ZGdWZncHRmT2NlY2hZS3NiZUVIM0w2bmJQUUZyQ0E0RFFVdE4tODg0QjlIM1VtVnVTMXJPRlhfTnFKM19FclJzb2lVaG84WE5IRFAzaFRLUTVTbFlXRUVWWl9lUnFzSFduVGdvRUk3OUc3aDBzZFBuTXln?oc=5) |
| Reuters | AbbVie sharpens immunology focus with $10.9 billion Apogee deal | [Source Link](https://news.google.com/rss/articles/CBMipwFBVV95cUxNdHUwZ3V2VWJfMjNDSjJEV0NkdHJBZTQ1dFQ0Y1FjdGY1NGsxZFdMbXo1N01Vei05R3dGZTN5MEFlcGJZc3Rmajh0dkZacmNCM2ZUZTVYMTM3TlZTVXNNOWRCVXg4dVkwRnBIUU1yT19ObnhJbW42eXU0OU1tNHgtQmZsZS1SR2RjMUJBanBLX3hCWFBIOS1XRDFGOTgzdW9kaHdzREN1dw?oc=5) |
| The Boston Globe | AbbVie to buy Waltham’s Apogee Therapeutics in nearly $11 billion deal | [Source Link](https://news.google.com/rss/articles/CBMilgFBVV95cUxPajI0bTZyaGp1ZUd1dzFtY1BaY3FPeVROV21tWHdDVmF2WGNmcTN4NzktYXpicXJXbVI3S21BUzBVWnJETEJwS2N2V1Y4Um5qV1FOckhja01NaGl3SV9lT1ZkTFNYWXV2UEFmLURlSENsQzNCWXc2REdBNWZTUnh0Z2xlUlVBN2V0dU9YR0wwa0tEVk1XWUE?oc=5) |
| FirstWord Pharma | Done deal: AbbVie to buy Apogee for $10.9B | [Source Link](https://news.google.com/rss/articles/CBMiU0FVX3lxTE0yTENnR2xEalBPVmxwVDJwS3lwNjE1b1c3cUJaYWoxRnNpVEZqNHpJdzR5MXdGU3VSTVRvbFF1Tkkydlc0SHU0djd4c3I2M1BleFBj?oc=5) |
| Whalesbook | US Stocks Steady Near Record Highs; AbbVie to Buy Apogee for $10.9 Billion | [Source Link](https://news.google.com/rss/articles/CBMi5AFBVV95cUxPcUVhUGFvc1J0ZkNfSHJqYVZkM0tlQnpLNmhnaWs0N2FCQ0NwSHVjNFg3dUNmcy1UUGVGYldKUm8yMWRyOGVjVHhoXzN0ZzNZTFlNQjRnU1RHQ1BIM2ZCcy1YeFRIM1BhTGFxS1MwaEcwSXFZLVpnXzBVbmIxdXJCZFNTU2RRNkpKVTRzc2hycDNqT0hjWDJPdnNobDJfY3dPNjJxaVlSdVhlYl9yR3lVUTNsZE1iNTFBNmhZU19fcll0UEpWbmlwajA2bG5jSFZXVE9ZWDJoTDNKcF9CdmZ2RVUybHg?oc=5) |
| GuruFocus | AbbVie's $10.9 Billion Apogee Deal Joins a $200 Billion Pharma Spree | [Source Link](https://news.google.com/rss/articles/CBMipgFBVV95cUxQTkk3MC1qNU1reXRDTkRpMk8ySlQtb013THplYURBWU02MlFBSV9LYXA0b3kwakFfZFpqLTN5a1ZCUnRZUlhuQXlKNk02S2ZKdGluV2tRRGFhQWJyRGZPcW9lTktKNFdobGhmbXZpMmJnaXdBelg1cGRZQUVsOFI1aUMyRzlKQjFKWjhEd0kwbGRCVm5oeXJUQmRLa2VLVWh6Q0lMWHR3?oc=5) |
| RAPS.org | Recon: AbbVie forges $10.9 billion deal with Apogee; US FDA changes tack on Regenxbio's rare disease gene therapy | [Source Link](https://news.google.com/rss/articles/CBMi3gFBVV95cUxNRGk4aGZjTUhZWlVDa1FIaTFSbXpwWjJQbUk1XzBQS3dXU3FtNHUwYWRCd3NDQXd2UG5vSF9SV2ctZWIxelFnb1BnUWJoZEI5SElleklBeVJoNTg1OVI4VkpXT1RBYW1EdGJmUlQ0Z0dOSVNoUXVqWE5oZURJTjVBOFJUSnNONEpreUs3WG03MFE4OG1MM0Jyb19uTWFHQTM1RGk1UEdxc2VhRndZV1BPV0dNcTl3VHctN3NYeWhfMkZYNk1BM2x4N0xVZnoxeVJLYjRNbWp0QTdFQzJDSXc?oc=5) |
| The Business Journals | AbbVie seals $10.9 billion deal to acquire biotech Apogee Therapeutics | [Source Link](https://news.google.com/rss/articles/CBMiowFBVV95cUxQNUsxVGZZZ3ZfemRQLWV4aTdXenBnV1U1alhtSWM2NjVtRkpOWDVvNlUwcnR4c3FrdXRUUHphNDZOeVlIMTZfTUxpa2xCNC1KZ1EwdHRpYnhZT3p0eDJhUGl1S0ZjQVNLSUZhbzNZcjc5RTBXMUdHS3RNaF9jd2JpOVlfeXpuU0R3cVVjbXR3TlVBUVR6TmFMMVdfa2ZPc3BIVjEw?oc=5) |

---
*Canonical Source: https://pulse.byoviral.com/trend/2026-06-22/abbvie-to-buy-immunology-drugmaker-apogee-for-10-9-billion*